Pantherx Specialty Pharmacy is not a DME supplier for medicare equipments and products.
Pantherx Specialty Pharmacy is a Specialty Pharmacy in Pittsburgh, Pennsylvania. This pharmacy is owned and operated by Pantherx Specialty Llc. It is located at 24 Summit Park Dr Ste 101, Pittsburgh and it's customer support contact number is 855-726-8479. The authorized person of Pantherx Specialty Pharmacy is Robert Snyder who is Ceo of the pharmacy and his contact number is 855-726-8479. Active license number of Pantherx Specialty Pharmacy is PP482247 for Specialty Pharmacy in Pennsylvania. Pantherx Specialty Pharmacy is a pharmacy that dispenses generally low volume and high cost medicinal preparations to patients who are undergoing intensive therapies for illnesses that are generally chronic, complex and potentially life threatening. Often these therapies require specialized delivery and administration.
Pharmacy Details:
Pantherx Specialty Pharmacy type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Pantherx Specialty Pharmacy
Type:
Specialty Pharmacy
Location:
24 Summit Park Dr Ste 101, Pittsburgh, Pennsylvania, 15275-1104
Phone:
855-726-8479
Fax:
855-246-3986
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Robert Snyder
Position:
Ceo
Contact Number:
855-726-8479
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1659762524
NPI Enumeration Date:
12 Feb, 2015
NPI Last Update On:
19 Sep, 2024
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Pantherx Specialty Pharmacy are as mentioned below.
Specialization
License Number
State
Status
Specialty Pharmacy
PP482247
Pennsylvania
Primary
Pharmacy
Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
1659762524
Medicaid
Iowa
1659762524
Medicaid
Michigan
Q044073
Medicaid
Tennessee
1659762524
Medicaid
Wisconsin
3535998
Medicaid
Louisiana
7100341470
Medicaid
Kentucky
9000154762
Medicaid
Colorado
004521280
Medicaid
Mississippi
0108012
Medicaid
Ohio
1659762524
Medicaid
Texas
179064
Medicaid
Alabama
3129668
Medicaid
New Hampshire
382281901
Medicaid
Texas
200566670A
Medicaid
Oklahoma
2068423
Medicaid
Washington
115359800
Medicaid
Florida
300005702
Medicaid
Indiana
30015069640004
Medicaid
Virginia
038969000
Medicaid
Puerto Rico
10026461101
Medicaid
Nebraska
4772202
Medicaid
New Mexico
500745115
Medicaid
Oregon
600027164
Medicaid
Missouri
003572
Medicaid
Hawaii
014205031
Medicaid
District Of Columbia
0484733
Medicaid
New Jersey
100549623
Medicaid
Nevada
110105692A
Medicaid
Massachusetts
1659762524
Medicaid
North Carolina
7P224D
Medicaid
South Carolina
089545
Medicaid
Arizona
100031262
Medicaid
Montana
151723600
Medicaid
Wyoming
1659762524
Medicaid
Maine
201105430A
Medicaid
Kansas
211567407
Medicaid
Arkansas
250630465
Medicaid
Delaware
3005296
Medicaid
Utah
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
24 Summit Park Dr, Suite 101 Pittsburgh, Pennsylvania
Zip:
15275-1104
Phone Number:
855-726-8479
Fax Number:
855-246-3986
Patients can reach Pantherx Specialty Pharmacy at 24 Summit Park Dr Ste 101, Pittsburgh, Pennsylvania or can call on customer care at 855-726-8479.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.